Long-Term Administration of Oral Physostigmine in Alzheimer's Disease
Neurol 38:1837-1841, Stern,Y.,et al, 1988
Effects of Oral Physostigmine in Alzheimer's Disease
Ann Neurol 22:306-310, Stern,Y.,et al, 1987
Physostigmine Improves ECT-Induced Memory Disturbances
Neurol 37:871-875, Levin,Y.,et al, 1987
Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984
Memory Enhancement with Oral Physostigmine in Alzheimer's Disease
NEJM 308:720-721, Thal,L.J.,et al, 1983
Oral Physostigmine & Lecithin Improve Memory in Alzheimer Disease
Ann Neurol 13:491-496, Thal,L.J.,et al, 1983
Memory Decline in the Aged:Treatment with Lecithin & Physostigmine
Neurol 32:944-950, Drachman,D.A.,et al, 1982
Double-blind, Triple-crossover Trial of Low Doses of Oral Physostigmine in Inherited Ataxias
Neurol 31:288-292, Kark,R.A.P.,et al, 1981
Amitriptyline-induced Ophthalmoplegia
Neurol 31:1188-1190, Spector,R.H.,et al, 1981
Physostigmine In Gilles De La Tourettes Syndrome
NEJM 302:298, Stahl,S.M.,et al, 1980
Memory & Cognitive Function in the Elderly, A Preliminary Trial of Physostigmine
Arch Neurol 37:674-675, Drachman,D.A.,et al, 1980
Anticholinergic Toxicity
NEJM 300:1278, Caine,E.D., 1979
Physostigmine in Reye Syndrome
Ann Neurol 5:105, Pettegrew,J.W.,et al, 1979
Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979
Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979
Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979
Amantadine Intoxication Reversed by Physostigmine
NEJM 298:516, Casey,D.E., 1978
Physostigmine in Familial Ataxias
Neurol 27:70, Kark,R.A.,et al, 1977
Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977
Total Gaze Paresis in Amitriptyline Overdose
Neurol 27:695, Miadinich,E.K.,et al, 1977